GlassScriptPhysician profile
Meng Gan
NPI 1649703901
$1,297.07
in general payments reported to CMS, 2019-2025
12 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.33 · 2022: $337 · 2023: $386 · 2024: $269 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $757.20 | 2022-2025 | Optune, Optune Lua (Novottf-200t) |
| Novartis Pharmaceuticals Corporation | $92.40 | 2023-2025 | |
| Springworks Therapeutics, INC. | $81.06 | 2024 | Ogsiveo |
| Astrazeneca Pharmaceuticals LP | $74.42 | 2021-2023 | Imfinzi |
| Telix Pharmaceuticals | $69.25 | 2023-2024 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $65.06 | 2023-2025 | |
| Boston Scientific Corporation | $36.47 | 2025 | Spaceoar Vue System - 10ml |
| Lilly USA, LLC | $28.86 | 2024 | |
| Teleflex LLC | $26.84 | 2024 | Urolift |
| Reflexion Medical, INC. | $24.65 | 2022 | |
| Eisai INC. | $22.26 | 2024 | |
| Janssen Scientific Affairs, LLC | $18.60 | 2025 | Erleada, Balversa, Akeega |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meng Gan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.